1,209
Participants
Start Date
February 12, 2013
Primary Completion Date
October 31, 2016
Study Completion Date
February 13, 2022
Abiraterone acetate
Abiraterone acetate tablets will be administered orally at a total dose of 1000 mg per day until disease progression, withdrawal of consent or unacceptable toxicity.
Prednisone
Prednisone 5 mg capsule will be administered orally once daily until disease progression, withdrawal of consent or unacceptable toxicity.
Androgen deprivation therapy (ADT)
All participants will receive stable regimen of ADT, that is, lutenizing hormone releasing hormone (LHRH) agonists or surgical castration according to local guidelines until disease progression, withdrawal of consent or unacceptable toxicity.
Abiraterone acetate Placebo
Placebo matched to abiraterone acetate will be administered orally once daily until disease progression, withdrawal of consent or unacceptable toxicity.
Prednisone Placebo
Placebo matched to prednisone will be administered orally once daily until disease progression, withdrawal of consent or unacceptable toxicity.
Buenos Aires
Caba
Córdoba
La Rioja
Rosario
Adelaide
Footscray
Liverpool
Malvern
Randwick
Wahroonga
Antwerp
Bonheiden
Brasschaat
Brussels
Charleroi
Liège
Namur
Ottignies
Sint-Niklaas
Yvoir
Barretos
Belo Horizonte
Caxias do Sul
Curitiba
Ijuí
Jaú
Natal
Novo Hamburgo
Porto Alegre
Ribeirão Preto
Rio de Janeiro
Salvador
São José do Rio Preto
São Paulo
Gabrovo
Sofia
Edmonton
Vancouver
Winnipeg
Hamilton
Kingston
Oshawa
Ottawa
Toronto
Montreal
Québec
Santiago
Beijing
Chengdu
Chongqing
Guangzhou
Hangzhou
Nanjing
Shanghai
Suzhou
Tianjin
Wuhan
Bogotá
Floridablanca
Medellín
Hradec Králové
Olomouc
Pilsen
Prague
Aarhus N
Holsterbro
Odense
Roskilde
Vejle
Oulu
Tampere
La Chaussée-Saint-Victor
Lille
Montpellier
Paris
Suresnes
Toulouse
Villejuif
Düsseldorf
Hamburg
Nürtingen
Budapest
Győr
Miskolc
Pécs
Szentes
Beer Yaakov
Beersheba
Haifa
Jerusalem
Kfar Saba
Petah Tikva
Ramat Gan
Chiba
Gifu
Kashiwa
Matsuyama
Nankoku
Ōsaka-sayama
Sakura
Tokushima
Tokyo
Ube
Yokohama
Yufu
Kuala Lumpur
Kuching
Chihuahua City
Cuernavaca
Durango
Guadalajara
Monterrey
Oaxaca City
Pachuca
Zapopan
Alkmaar
Amsterdam
Amsterdam-Zuidoost
Hilversum
Hoofddorp
Nieuwegein
Rotterdam
Auckland
Christchurch
Hamilton
Tauranga
Bydgoszcz
Gdansk
Lodz
Lublin
Warsaw
Braga
Coimbra
Lisbon
Porto
Brasov
Bucharest
Cluj-Napoca
Iași
Chelyabinsk
Ivanovo
Izhevsk
Moscow
Nizhny Novgorod
Obninsk
Omsk
Orenburg
Pyatigorsk
Rostov-on-Don
Ryazan
Saint Petersburg
Saransk
Saratov
Sochi
Stavropol
Tyumen
Ufa
Volgograd
Yekaterinburg
Yoshkar-Ola
Košice-Šaca
Martin
Piešťany
Prešov
Rimavská Sobota
Trnava
George
Port Elizabeth
Pretoria
Vosloorus
Bucheon-si
Busan
Daegu
Daejeon
Gyeonggi-do
Seoul
A Coruña
Barcelona
Córdoba
Madrid
Murcia
Gothenburg
Malmo
Stockholm
Umeå
Uppsala
Adana
Ankara
Istanbul
Izmir
Zonguldak
Cherkassy
Dnipro
Khakhiv
Kharkiv
Kyiv
Lviv
Makiivka
Odesa
Uzhhorod
Zaporizhzhia
Cambridge
Glasgow
Manchester
Nottingham
Oxford
Plymouth
Janssen Research & Development, LLC
INDUSTRY